Sonendo has announced its third EndoCon, a comprehensive program covering the latest in endodontic technology and innovation. Taking place in San Diego at the Manchester Grand Hyatt from Oct. 5-7, the three-day event will offer lectures, workshops, and training sessions for clinicians, staff, and postgraduate residents.
EndoCon aims to provide something for everyone, giving endodontists and their teams access to decades worth of experience and knowledge from master clinicians and endodontic thought leaders. The schedule is comprised of world-class clinical and practice management lectures, continuing education sessions, and hands-on learning opportunities. The scientific, expert, and keynote continuing education sessions will focus on compelling and forward-looking topics including growth mindset—the art and science of success, artificial intelligence (AI) in medical imaging, leveraging AI for business success, and modern AI pathology platform solutions.
“We remain committed to driving innovation and excellence in endodontics and supporting industry professionals as best we can,” said Michael Smith, chief commercial officer at Sonendo. “EndoCon embodies our dedication to advancing the field and providing clinicians and their teams with the tools and knowledge they need to succeed and, most importantly, deliver exceptional patient care.”
Additionally, the event provides an opportunity for attendees to network and socialize, with special events including a welcome reception, resident and program director luncheon, and Women in Endodontics luncheon.
EndoCon attendees will also gain insights into how the GentleWave System can support practice growth, streamline workflows, and enhance overall patient care. For additional information on EndoCon, visit here.
About Sonendo
Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.
Source: www.gentlewave.com/doctor
News 27 March 2026
Sonendo, Inc. (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today reported select preliminary financial results for the year...
News 29 August 2025
Sonendo, Inc., a leading dental technology company and developer of the GentleWave System, announced select financial results for the quarter ended June 30, 2025, and reaffirmed its full-year...
News 13 June 2025
Sonendo, Inc. (“Sonendo” or the “Company”) (OTC Pink: SONX), a leading dental technology company and developer of the GentleWave® System, today reported select financial results for the...
News 08 August 2024
Sonendo announced that it will report financial results for the second quarter of 2024 after the market close on Wednesday, August 7th, 2024.
Sonendo has announced the appointment of John Bostjancic as chief financial officer, the appointment of Robert Guyatt as senior vice president of marketing, and the promotion of John McGaugh to...
You may have noticed that more and more of your patients have started seeking toothpastes that are free of Sodium Lauryl Sulfate (SLS).
News 22 April 2026
Multi-segment series highlights how oral health connects to overall health and why connected care matters
News 22 April 2026
The New York State Dental Association (NYSDA) today called on state lawmakers to reject proposed reductions to the pass-through entity tax (PTET) credit
Graduating students presented research spanning artificial intelligence, clinical care, and global health
Implantology 22 April 2026
To update in new biopolymers and innovations for ocular prostheses and visual implants for visual care.